PCM
BTAL icon

Prelude Capital Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Prelude Capital Management’s Portfolio BTAL Stock Details BTAL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-16,000
Closed -$300K – 1150
2023
Q2 		$300K Buy
+16,000
New +$323K 0.02% 643

Other funds holding BTAL

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
TWM
TMD Wealth Management Scottsdale, Arizona $456M AUM 11.92% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.37B AUM 19.43% 1-Year Est. Return
FGA
Fortis Group Advisors Westwood, New Jersey $605M AUM 28.64% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Prelude Capital Management's BTAL Position: Q3 2023 in Review

Prelude Capital Management sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q3 2023, closing a stake of 16,000 shares — an estimated $300K sold.

Prelude Capital Management first reported a position in BTAL in Q2 2023 and held it in 1 quarter. The position peaked at $300K in Q2 2023. 76 funds tracked by Wall St. Rank hold BTAL as of Q3 2023.

  • Prelude Capital Management reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q3 2023 after selling out during the quarter.
  • Prelude Capital Management sold 16,000 AGF US Market Neutral Anti-Beta Fund shares in Q3 2023, an estimated $300K.
  • Prelude Capital Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q2 2023 and held it in 1 quarter.
  • Prelude Capital Management's AGF US Market Neutral Anti-Beta Fund position peaked at $300K in Q2 2023.
  • 76 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2023.

Based on Prelude Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.